SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 167 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,112,000 | +24.5% | 242,062 | +21.9% | 0.01% | +16.7% |
| Q3 2016 | $4,909,000 | +27.2% | 198,503 | +4.8% | 0.01% | +20.0% |
| Q2 2016 | $3,860,000 | +81.7% | 189,480 | +36.0% | 0.01% | +66.7% |
| Q1 2016 | $2,124,000 | +6.1% | 139,290 | -6.5% | 0.00% | 0.0% |
| Q4 2015 | $2,002,000 | +4.7% | 148,938 | +9.3% | 0.00% | 0.0% |
| Q3 2015 | $1,912,000 | -17.9% | 136,268 | -0.7% | 0.00% | 0.0% |
| Q2 2015 | $2,330,000 | +125.6% | 137,239 | +60.6% | 0.00% | +200.0% |
| Q1 2015 | $1,033,000 | +46.5% | 85,470 | +0.6% | 0.00% | 0.0% |
| Q4 2014 | $705,000 | -5.2% | 84,931 | -0.8% | 0.00% | 0.0% |
| Q3 2014 | $744,000 | -19.4% | 85,644 | +1.6% | 0.00% | 0.0% |
| Q2 2014 | $923,000 | +89.5% | 84,276 | +54.8% | 0.00% | 0.0% |
| Q1 2014 | $487,000 | +46.7% | 54,445 | +23.7% | 0.00% | – |
| Q4 2013 | $332,000 | +7.1% | 44,025 | +4.0% | 0.00% | -100.0% |
| Q3 2013 | $310,000 | +22.5% | 42,331 | +7.7% | 0.00% | – |
| Q2 2013 | $253,000 | – | 39,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |